Bortezomib and Ganciclovir in Treating Patients With Relapsed or Refractory Epstein Barr Virus-Positive Lymphoma
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Abramson Cancer Center at Penn Medicine
National Institutes of Health Clinical Center (CC)
AIDS Malignancy Consortium
City of Hope Medical Center
Huazhong University of Science and Technology
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Boston Medical Center
University of Alabama at Birmingham
HemaQuest Pharmaceuticals Inc.
HemaQuest Pharmaceuticals Inc.
Fred Hutchinson Cancer Center